Brief: Synthaverse Says Drug Onko BCG Gets Registered On Territory Of France
July 2 (Reuters) - Synthaverse SA SVEP.WA :
* ITS DRUG GETS REGISTERED ON TERRITORY OF FRANCE
* NAME OF DRUG IS ONKO BCG
* DRUG TO BE INTRODUCED ON FRENCH MARKET WITHIN 6 MONTHS
FROM
SETTING REFUND PRICE OF PRODUCT
Source text for Eikon: ID:nEM450Hbra
Further company coverage: SVEP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility